Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

NCT05065372 is registered in ClinicalTrials.gov with Kalie Tommerdahl as lead sponsor.

NCT NCT05065372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05065372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
Lead sponsor
Kalie Tommerdahl
Phase
Phase 1
Overall status
Recruiting
Start date
July 1, 2022
Completion date
July 31, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, diabetic kidney disease, endothelial dysfunction, insulin sensitivity, type 1 diabetes